Citadel Advisors
SYNH

Citadel Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Citadel Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28,800
Closed -$1.21M – 15464
2023
Q2 		$1.21M Buy
28,800
+12,800
+80% +$518K ﹤0.01% 6062
2023
Q1 		$570K Buy
16,000
+14,100
+742% +$512K ﹤0.01% 8057
2022
Q4 		$69.7K Sell
1,900
-7,100
-79% -$281K ﹤0.01% 11707
2022
Q3 		$424K Buy
9,000
+200
+2% +$12.9K ﹤0.01% 8830
2022
Q2 		$631K Sell
8,800
-11,500
-57% -$841K ﹤0.01% 8129
2022
Q1 		$1.64M Buy
20,300
+16,100
+383% +$1.36M ﹤0.01% 6530
2021
Q4 		$431K Sell
4,200
-6,200
-60% -$595K ﹤0.01% 10037
2021
Q3 		$910K Sell
10,400
-6,200
-37% -$561K ﹤0.01% 8399
2021
Q2 		$1.49M Buy
16,600
+2,100
+14% +$177K ﹤0.01% 7337
2021
Q1 		$1.1M Hold
14,500
– – ﹤0.01% 7879
2020
Q4 		$988K Buy
14,500
+7,800
+116% +$486K ﹤0.01% 6816
2020
Q3 		$356K Sell
6,700
-3,400
-34% -$202K ﹤0.01% 7857
2020
Q2 		$588K Buy
10,100
+200
+2% +$10.7K ﹤0.01% 6786
2020
Q1 		$390K Buy
9,900
+2,900
+41% +$170K ﹤0.01% 6869
2019
Q4 		$416K Buy
+7,000
New +$376K ﹤0.01% 7102
2019
Q3 		– Sell
-4,300
Closed -$220K – 9923
2019
Q2 		$220K Sell
4,300
-9,200
-68% -$428K ﹤0.01% 8060
2019
Q1 		$699K Buy
+13,500
New +$654K ﹤0.01% 6219
2018
Q4 		– Sell
-7,600
Closed -$392K – 9944
2018
Q3 		$392K Sell
7,600
-9,400
-55% -$460K ﹤0.01% 7115
2018
Q2 		$797K Buy
17,000
+5,300
+45% +$219K ﹤0.01% 5595
2018
Q1 		$415K Buy
11,700
+4,800
+70% +$188K ﹤0.01% 6223
2017
Q4 		$301K Buy
+6,900
New +$322K ﹤0.01% 6458
2016
Q1 		– Sell
-200
Closed -$10K – 8254
2015
Q4 		$10K Sell
200
-700
-78% -$31.1K ﹤0.01% 8283
2015
Q3 		$36K Buy
+900
New +$39.3K ﹤0.01% 7803

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's SYNH Position: Q3 2023 in Review

Citadel Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 33,500 shares — an estimated $1.41M sold.

Citadel Advisors first reported a position in SYNH in Q4 2014 and held it in 33 quarters. The position peaked at $139M in Q4 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Citadel Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 33,500 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.41M.
  • Citadel Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 33 quarters.
  • Citadel Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $139M in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.